Atherosclerosis
895
61
85
572
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
98 trials with published results (11%)
Research Maturity
572 completed trials (64% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
5.8%
52 terminated out of 895 trials
91.7%
+5.2% vs benchmark
19%
170 trials in Phase 3/4
17%
98 of 572 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 572 completed trials
Clinical Trials (895)
Characterization of Patients With Uncommon Presentations and/or Uncommon Diseases Associated With the Cardiovascular System
Study of the Effect of Innate on the Inflammatory Response to Endotoxin
Causes and Natural History of Dyslipidemias
PET/CT* vs. Cardiac CT for Detecting Coronary Atherosclerotic Disease [*PET: Positron Emission Tomography; CT: Computed Tomography]
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
Using Indoor Air Filtration to Slow Atherothrombosis Progression in Adults With Ischemic Heart Disease History
New Heart Imaging Techniques to Evaluate Possible Heart Disease
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Measuring Athlete's Risk of Cardiovascular Events 3 (MARC-3)
Pilot Study Evaluating the Impact of Stress Reduction on Atherosclerotic : Heart and Mind Study
TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes
A Study to See if Lepodisiran Can Reduce Plaque in Coronary Arteries of Adults With Elevated Lp(a) Who Have Had Heart Events or Are at High Risk
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
Leucine, mTOR and Athero
High Protein Diet and Atherosclerosis
Blood Endothelium Biomarkers to Predict Major Adverse Cardiovascular Events After Percutaneous Coronary Intervention
Clopidogrel Versus Cilostazol on Vessels
Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia